Abstract. Cementum is a highly specialized connective tissue that covers tooth roots. The only cementum-specific protein described to date is the cementum attachment protein (CAP). A putative sequence for CAP was established from a cDNA clone isolated from a human cementifying fibroma cDNA library. This sequence overlaps with a phosphatase-like protein in muscle termed the protein-tyrosine phosphatase-like member A (PTPLA). To clarify the nature of CAP/PTPLA, we cloned the homologous rat protein and determined its sequence. The rat protein shared 94% sequence identity with the human protein. On Northern blots containing RNA from various rat tissues of different developmental stages, the cDNA hybridized to an mRNA expressed in heart and skeletal muscle but not in teeth. These results were confirmed by real-time PCR. Thus, the sequence deposited in public databanks under the name 'cementum attachment protein' does not represent genuine CAP.
Introduction
Cementum is a thin calcified layer of connective tissue that covers the root surfaces of the teeth (1) . It plays a critical role during regeneration of periodontal tissues (1) (2) (3) . Very little is known about this process since specific molecular markers for cementum are still lacking. The matrix of cementum resembles that of bone and consists of collagens (types I and III), fibronectin, osteopontin, bone sialoprotein, osteocalcin and vitronectin. To date, only a single cementum-specific protein, namely cementum attachment protein (CAP), has been described (2, 4) . CAP is a collagen-like protein distinct from collagens I, XII and XIV. It promotes cell attachment of fibroblasts and other periodontal cells and its activity is mediated by ·5‚1 integrin receptors on cell surfaces. When isolated from human or bovine cementum, CAP has a molecular mass of 55-56 kDa. Two monoclonal antibodies were generated against CAP (5, 6) . Experiments with these antibodies revealed that CAP was restricted to the cementum matrix and to cementoblasts.
Recently, a protein was cloned from a human cementifying fibroma and its sequence (GenEMBL accession number AY455942) was deposited in public databanks under the name 'cementum attachment protein'. The predicted protein consists of 140 amino acid residues with a molecular mass of 15 kDa (AAR22554). Since this sequence is not yet described in a scientific report, its authenticity remains uncertain. The Nterminal half of the sequence overlaps with the sequence of a novel phosphatase-like gene termed PTPLA (protein-tyrosine phosphatase-like member A) (7, 8) . PTPLA is expressed primarily in cardiac and skeletal muscle, suggesting that it might play a role during cardiogenesis and myogenesis. Recently, mutations in the PTPLA gene were found in a dog studied as a model for autosomal recessive centronuclear myopathy (9) . It is therefore concluded that impaired signaling of PTPLA might be implicated in human myopathies.
Material and methods
DNA sequencing. Expressed sequence tags (ESTs) for rat genes were obtained from the Program for Rat Gene Discovery at the University of Iowa (UI-R-AA0-wo-d-07-0-UI.s10, UI-R-BJ1-atk-f-10-0-UI.s10, UIR-CN1-cji-f-16-0-UI.s10). The EST clones were sequenced by the dideoxy chain termination method with a cycle sequencing machine (ABI 3730). The sequences were analyzed with the GCG computer program (Accelrys Cambridge, UK) run on a UNIX SUN computer (Solaris 9). Databank comparisons were performed at the National Center for Biotechnology Information (www.ncbi. nlm.nih.gov).
RNA isolation and Northern blot analysis. Total RNA was extracted from various rat tissues by the guanidinium isothiocyanate method (10, 11) utilizing the RNeasy kit from Qiagen GmbH (Hilden, Germany). Samples from different developmental stages were homogenized with a polytron (Kinematica AG Lucerne, Switzerland). The purified RNA was separated on a 1% agarose gel in the presence of formaldehyde and transferred to a Nylon membrane by vacuum blotting (12).
The blot was hybridized overnight at 42˚C with radioactively labeled cDNA probes in a buffer containing 50% formamide. These probes were labeled with [·-
32 P]-dCTP by the random primed oligolabeling method (11, 13) . After washing with standard saline citrate (SSC), the blot was exposed to X-ray film (12) .
Quantitative PCR. Total RNA from various tissues was denatured at 65˚C and cooled to room temperature. The RNA (1 μg) was transcribed into first strand cDNA by reverse transcriptase from Moloney Murine Leukemia Virus (1.5 U/μl) as suggested by the supplier of the enzyme (Stratagene). Random hexamers served as primers. The cDNA samples were analyzed by real-time PCR with the ABI 7700 Sequence Detection System utilizing the SYBR Green PCR master mix (Applied Biosystems). The following primer pairs were used: rat S9 up GAGCTGTTGACGCTGGACGAGAAG, rat S9 low GGCCACCACCATAAGGAGAAAGGAG (annealing temperature 65˚C), rat CAP up CCGCCTGGCTCACCTTCT ACAATATC, rat Cap low CCATGAAGATTCGTGAACTC ACTTGGAC (annealing temperature 65˚C). All experiments were performed in triplicate and normalized to results obtained with ribosomal protein S9.
Results and discussion
A detailed comparison of the sequences from CAP (GenEMBL accession number AY455942) and PTPLA (AF114494) suggested that the two proteins are a result of an alternative splicing event. The human PTPLA gene encompasses seven exons. The CAP sequence contains exons 1-4 but also includes introns 2, 3 and 4 ( Fig. 1) . Termination of translation occurs within intron 2, 16 codons downstream of the exon/intron splice boundary. When all EST clones available in the GenEMBL databank were analyzed for alternative splice variants, it was evident that PTPLA is particularly susceptible to alternative splicing. Variants missing either one or several of the exons 2, 3, 4 and 5 were identified. In addition, some isoforms were observed that still possessed part of the introns. One variant (CN305861) was identical to the CAP sequence, demonstrating that AY455942 is not simply a cloning artifact.
There are several examples where two alternative transcripts from a single gene fulfill distinct functions. An example studied recently in our laboratory concerned LIM-nebulette (14) . LIM-nebulette is transcribed from an alternative promoter of the nebulette gene. It is expressed at focal adhesions of non-muscle cells whereas nebulette is found exclusively in the sarcomere of cardiac muscle cells (14) .
We therefore investigated whether a similar mechanism might account for the existence of two splice variants transcribed from the CAP/PTPLA gene, one acting as the phosphatase-like protein expressed in muscles, the other acting as CAP in teeth. Clones for the homologous PTPLA protein were isolated from a rat EST clone library and sequenced completely. The assembled cDNA was found to contain 951 nucleotides with a typical polyadenylation signal and a short poly (A) tail (deposited in GenEMBL under AM260199). The rat cDNA sequence showed 88% identity with the human cDNA sequence. It harbored an open reading frame of 744 bp that could translate into a protein of 248 amino acid residues. Compared to the human PTPLA protein, the predicted rat protein shared 94% sequence identity or 97% similarity if conservative amino acid substitutions are included (Fig. 2) . A comparison with the rat genomic sequence further demonstrated that the rat gene comprised 7 exons like the human gene. The positions of all introns and the splice phases matched those of the human homologue. The PTPLA gene has therefore been highly conserved during evolution.
To analyze the tissue-specific expression of CAP/PTPLA, Northern blots were prepared with RNA extracted from 8 different rat tissues, including teeth and skeletal muscle (Fig. 3) . Our cDNA probe hybridized specifically with a mRNA of ~1000 nucleotides that was expressed in skeletal muscle, heart and tongue, but not in teeth. Subsequent hybridization of the same blot with a probe specific for rat ameloblastin (positive control) yielded a typical doublet of 2000 nucleotides that was present only in the lane for teeth (Fig. 3) .
Since there is the possibility that the CAP/PTPLA gene is expressed in teeth only at a specific developmental stage, we performed similar Northern blotting experiments with different tissues obtained from rats 6, 12, 24 and 45 days after birth. Entire mandibles (6 and 12 days) as well as individual teeth (24 and 45 days) were compared with probes obtained from skeletal muscles of the same developmental stage. Incisors and molars of 45 days were analyzed in combination as well as separately. Again, expression of the CAP/PTPLA gene was restricted to muscular tissues (Fig. 4) . Expression of the ameloblastin gene, however, was restricted to teeth and mandibles.
Since Northern blotting is not an extremely sensitive technique, we confirmed the results by quantitative PCR. All RNA preparations were transcribed separately into cDNA and analyzed with a primer pair specific for the CAP/PTPLA gene. The results were normalized to the expression level of the ribosomal protein S9 determined in parallel in the same tissue. Expression of CAP/PTPLA was observed in all samples from the muscular tissues (Fig. 5) . However, no expression of CAP/PTPLA that exceeded background noise was observed in the mandibles or in the teeth.
Our experiments clearly demonstrate that the CAP/PTPLA gene is expressed in muscles but not in teeth. The possibility that our Northern blot probe would hybridize exclusively with the normal splice variant but not with the alternatively spliced version can be ruled out since it overlaps with the entire 5' half of the alternatively spliced CAP/PTPLA mRNA. Thus, sequence AY455942 deposited in public databanks and annotated as 'cementum attachment protein' does not represent genuine CAP from teeth. This conclusion is supported by the fact that sequence AY455942 encodes a 15 kDa protein lacking any Gly-X-Y repeats as they are typically found in collagen-like proteins. Originally, CAP was described as a collagen-like protein of 55 kDa (2) .
